Drug Prices
The House Energy and Commerce Subcommittee on Health today held a hearing examining the increasing cost of prescription drugs in the Medicare program and ways to improve coverage and reduce costs for seniors.
AHA letter to Senator Richard J. Durbin expressing support for legislation, S. 551, the Recovering Excessive Funds for Unused and Needless Drugs (REFUND) Act.
The Senate Finance Committee held on Tuesday the third in a series of hearings on drug pricing in America, which focused on the role of pharmacy benefit managers.
The House Energy and Commerce Subcommittee on Oversight and Investigations today held the second part of a hearing on the rising cost of insulin, which featured witnesses from the nation’s three insulin manufacturers as well as three pharmacy benefit managers.
A Department of Health and Human Services’ Office of Inspector General proposal to change drug discount safe harbors under the federal anti-kickback statute would likely increase premiums for Medicare beneficiaries without addressing the nation’s high and rising drug prices, the AHA said.
In its worst quarter since forming the Walgreens Boots Alliance with European drugstore chain Alliance Boots GmbH, the Deerfield, Ill.-based retailer says it will further expand its aggressive cost-cutting strategy, adding another $500 million in cuts to the $1 billion previously announced. The…
A Department of Health and Human Services' Office of Inspector General proposal to change drug discount safe harbors under the federal anti-kickback statute would likely increase premiums for Medicare beneficiaries without addressing the nation's high and rising drug prices, the AHA said.
The House Committee on Energy and Commerce yesterday passed a number of AHA-supported bills that would lower prescription drug costs and strengthen the Affordable Care Act marketplaces to improve access and lower the cost of coverage for consumers.
The AHA expressed support for a number of bills being considered today by the House Committee on Energy and Commerce that would lower prescription drug costs and strengthen the Affordable Care Act marketplaces to improve access and lower the cost of coverage for consumers.
AHA applauds the Committee on Energy and Commerce for considering legislation to lower prescription drug costs and strengthen the Affordable Care Act marketplaces to improve access and lower the cost of coverage for consumers.